In 2017, the global market for continuous peripheral nerve block (cPNB) catheters was valued at USD 181.4 million. Over the forecast period, it is expected to grow at a CAGR of 6.2 percent. The growing senior population is driving up the demand for postoperative pain management solutions, which is driving up the volume of orthopaedic procedures. Furthermore, in major orthopaedic procedures, cPNBs are rapidly replacing traditional regional anaesthetic approaches. One of the important aspects in driving market expansion is the growing volume of surgeries along with the growing requirement for effective postoperative care.
The increased prevalence of osteoarthritis, the most common joint condition, has resulted in an increase in the number of joint replacements and arthroplasties during the last decade. According to the International Association for the Study of Pain, symptomatic osteoarthritis affected between 10% to 15% of the global population in 2016. The world's population is ageing, and the prevalence of osteoarthritis is rising, which is contributing to an increase in the number of orthopaedic surgery.
CPNB catheters are also useful in the event of amputation of a major limb. A considerable majority of cases include lower extremity amputations due to diabetic foot ulceration. The International Diabetes Federation estimates that the global diabetes population will grow from 424.9 million in 2017 to 628.6 million in 2045. The market is likely to be propelled by an upward trend in the number of amputations performed around the world.
Patients who have had joint replacements or arthroplasties, as well as limb amputations, commonly endure post-operative discomfort. After ambulatory surgery, around a third of patients report moderate to severe postoperative discomfort. The use of long-acting opioids to combat this has been linked to a variety of side effects, including nausea, vomiting, and sleep disturbance. Using cPNB catheters for regional anaesthetic, on the other hand, results in superior postsurgical outcomes and reduces long-acting opioid side effects. As a result, declining opioid preference in pain management is accountable for catastrophizing the overall rise of catastrophizing.
The ultrasonic category has the biggest market share of 48.2 percent based on the insertion technique. This is due to benefits such as better block quality, faster and longer block duration, and the requirement for a lower dose of local anaesthetic. Because of the decreased pain index associated with ultrasound-guided insertion, this approach is becoming more popular for paediatric regional anaesthesia.
The nerve stimulation segment, on the other hand, is expected to grow at a slow rate of 1.9 percent throughout the projected period. Due to the introduction of new sophisticated technologies such as ultrasound-guided catheter placement, this is the oldest existing technology (after blind advancement) for catheter placement.
Because of the growing number of procedures requiring the use of these devices, lower extremity surgeries accounted for a higher part of the cPNB catheters market. Effective postoperative care, along with an increase in lower-limb procedures, has a significant impact on overall postoperative outcomes, including shorter hospital stays, earlier mobilisation, less postoperative nausea, and lower readmission rates.
cPNB catheters are increasingly being used for successful pain management in major upper limb procedures involving prolonged post-operative pain, such as complete shoulder replacement, rotator cuff surgery, and elbow replacements. As a result of this trend, the upper extremity surgeries market is expected to grow at a stable rate over the forecast period.
Over the projected period, the ambulatory surgery centres segment is expected to increase at a compound annual growth rate of 7.2 percent. Shorter wait times, faster release, lower overall procedure costs, and treatment for a larger number of patients are all advantages of day-care surgery centres. The number of ASCs is expected to grow as healthcare costs rise in industrialised countries and as public knowledge of the benefits of these facilities grows. The uptake of cPNB catheters will be triggered as a result of this.
Comments
Post a Comment